Incyte (INCY) Operating Income (2010 - 2026)
Incyte posted quarterly Operating Income of $301.1 million for Q1 2026, up 46.77% year-on-year from $205.2 million in Q1 2025, and down 10.34% on a QoQ basis from $335.9 million in Q4 2025.
Incyte (INCY) has 17 years of Operating Income data on file, last reported at $301.1 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 46.77% year-over-year to $301.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (up 822.38% YoY), and the FY2025 full-year result was $1.5 billion, up 2368.56% from the prior year.
- Operating Income for Q1 2026 stood at $301.1 million, down from $335.9 million in the prior quarter.
- Across five years, Operating Income topped out at $530.3 million in Q2 2025 and bottomed at -$478.1 million in Q2 2024.
- The 5-year median for Operating Income is $193.8 million (2023), against an average of $181.0 million.
- Peak annual rise in Operating Income reached 271.01% in 2024, while the deepest fall reached 346.74% in 2024.
- A 5-year view of Operating Income shows it stood at $70.1 million in 2022, then soared by 167.17% to $187.3 million in 2023, then soared by 61.0% to $301.5 million in 2024, then climbed by 11.39% to $335.9 million in 2025, then slipped by 10.34% to $301.1 million in 2026.
- The last three Operating Income figures came in at $301.1 million (Q1 2026), $335.9 million (Q4 2025), and $443.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 301.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 301.12 Mn |
| Dec 31, 2025 | 335.86 Mn |
| Sep 30, 2025 | 443.52 Mn |
| Jun 30, 2025 | 530.31 Mn |
| Mar 31, 2025 | 205.17 Mn |
| Dec 31, 2024 | 301.51 Mn |
| Sep 30, 2024 | 146.09 Mn |
| Jun 30, 2024 | -478.13 Mn |
| Mar 31, 2024 | 91.90 Mn |
| Dec 31, 2023 | 187.27 Mn |
| Sep 30, 2023 | 214.71 Mn |
| Jun 30, 2023 | 193.78 Mn |
| Mar 31, 2023 | 24.77 Mn |
| Dec 31, 2022 | 70.09 Mn |
| Sep 30, 2022 | 138.38 Mn |
| Jun 30, 2022 | 254.43 Mn |
| Mar 31, 2022 | 116.54 Mn |
| Dec 31, 2021 | 110.73 Mn |
| Sep 30, 2021 | 235.41 Mn |
| Jun 30, 2021 | 140.84 Mn |
| Mar 31, 2021 | 98.80 Mn |
| Dec 31, 2020 | 164.23 Mn |
| Sep 30, 2020 | 5.33 Mn |
| Jun 30, 2020 | 230.77 Mn |
| Mar 31, 2020 | -664.00 Mn |
| Dec 31, 2019 | 95.01 Mn |
| Sep 30, 2019 | 134.32 Mn |
| Jun 30, 2019 | 98.61 Mn |
| Mar 31, 2019 | 74.07 Mn |
| Dec 31, 2018 | -23.03 Mn |
| Sep 30, 2018 | 31.12 Mn |
| Jun 30, 2018 | 83.24 Mn |
| Mar 31, 2018 | -67.11 Mn |
| Dec 31, 2017 | 1.67 Mn |
| Sep 30, 2017 | 15.02 Mn |
| Jun 30, 2017 | 7.26 Mn |
| Mar 31, 2017 | -133.25 Mn |
| Dec 31, 2016 | -65.33 Mn |
| Sep 30, 2016 | 22.29 Mn |
| Jun 30, 2016 | 44.59 Mn |
| Mar 31, 2016 | 36.04 Mn |
| Dec 31, 2015 | 17.07 Mn |
| Sep 30, 2015 | -101,000.00 |
| Jun 30, 2015 | -7.39 Mn |
| Mar 31, 2015 | -6.94 Mn |
| Dec 31, 2014 | -25.62 Mn |
| Sep 30, 2014 | 69.94 Mn |
| Jun 30, 2014 | -26.19 Mn |
| Mar 31, 2014 | -22.94 Mn |
| Dec 31, 2013 | -29.04 Mn |
| Sep 30, 2013 | -13.18 Mn |
| Jun 30, 2013 | 17.32 Mn |
| Mar 31, 2013 | -4.10 Mn |
| Dec 31, 2012 | 13.66 Mn |
| Sep 30, 2012 | -10.14 Mn |
| Jun 30, 2012 | 15.22 Mn |
| Mar 31, 2012 | -34.19 Mn |
| Dec 31, 2011 | -44.14 Mn |
| Sep 30, 2011 | -42.10 Mn |
| Jun 30, 2011 | -41.11 Mn |
| Mar 31, 2011 | -15.83 Mn |
| Dec 31, 2010 | 17.12 Mn |
| Sep 30, 2010 | -22.06 Mn |
| Jun 30, 2010 | 13.62 Mn |
| Mar 31, 2010 | -19.83 Mn |